Vitamin D3 inhibits the proliferation of T helper cells, downregulate CD4+ T cell cytokines and upregulate inhibitory markers

被引:47
作者
Sheikh, Vida [1 ]
Kasapoglu, Pinar [2 ]
Zamani, Alireza [3 ]
Basiri, Zahra [1 ]
Tahamoli-Roudsari, Ahmad [1 ]
Alahgholi-Hajibehzad, Mahdi [3 ]
机构
[1] Hamadan Univ Med Sci, Sch Med, Dept Internal Med, Hamadan, Iran
[2] Bakirkoy Dr Sadi Konuk Training & Res Hosp, Dept Biochem, Istanbul, Turkey
[3] Hamadan Univ Med Sci, Sch Med, Dept Immunol, Hamadan, Iran
关键词
Cytolcine; T cell; Vitamin D3; PD1; CTLA4; D-RECEPTOR; MYASTHENIA-GRAVIS; MYCOBACTERIUM-TUBERCULOSIS; 1,25-DIHYDROXYVITAMIN D-3; IMMUNE-SYSTEM; D DEFICIENCY; INFECTION; AUTOIMMUNITY; INFLAMMATION; CALCITRIOL;
D O I
10.1016/j.humimm.2018.03.001
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
1 alpha, 25-dihydroxyvitamin D3 (VitD3) has been suggested to have strong modulatory properties in the immune system. Researchers in the present study primarily aimed to understand the effect of VitD3 on human CD4(+) T cell proliferation in antigen presenting cells (APCs) free condition in vitro. The effect of VitD3 on intracellular cytokine responses trend to Th1, Th2, Th17 and Th22 was evaluated using the flow cytometry. Moreover the effect of VitD3 on the expression of inhibitory markers such as PD1, PD-L1, and CTLA4 which are induced upon polyclonal T cell receptor (TCR) activation on CD4(+) T cells, was assessed. We observed that the stimulation of CD4(+) T cells with VitD3, suppressed proliferation capacity, enhanced the expression of PD1, PD-L1 and CTLA4 inhibitory markers on CD4(+) T cells, and diminished the percentage of pro-inflammatory cytokines including, IFN-gamma, IL-17, and IL-22 except IL-4 in CD4(+) T cells. The data suggested a potential insight into the consideration of VitD3 in the prevention/control of pro-inflammatory immune response/autoimmune disorders.
引用
收藏
页码:439 / 445
页数:7
相关论文
共 50 条
[1]   Unexpected actions of vitamin D: new perspectives on the regulation of innate and adaptive immunity [J].
Adams, John S. ;
Hewison, Martin .
NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM, 2008, 4 (02) :80-90
[2]   The effect of interleukin (IL)-21 and CD4+CD25++ T cells on cytokine production of CD4+ responder T cells in patients with myasthenia gravis [J].
Alahgholi-Hajibehzad, M. ;
Durmus, H. ;
Aysal, F. ;
Guelsen-Parman, Y. ;
Oflazer, P. ;
Deymeer, F. ;
Saruhan-Direskeneli, G. .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2017, 190 (02) :201-207
[3]  
Alahgholi-Hajibehzad M., 2017, CLIN EXP IMMUNOL
[4]   The role of T regulatory cells in immunopathogenesis of myasthenia gravis: implications for therapeutics [J].
Alahgholi-Hajibehzad, Mahdi ;
Kasapoglu, Pinar ;
Jafari, Reza ;
Rezaei, Nima .
EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2015, 11 (07) :859-870
[5]   Regulatory function of CD4+CD25++ T cells in patients with myasthenia gravis is associated with phenotypic changes and STAT5 signaling: 1,25-Dihydroxyvitamin D3 modulates the suppressor activity [J].
Alahgholi-Hajibehzad, Mandi ;
Oflazer, Piraye ;
Aysal, Fikret ;
Durmus, Hacer ;
Gulsen-Parman, Yesim ;
Marx, Alexander ;
Deymeer, Feza ;
Saruhan-Direskeneli, Guher .
JOURNAL OF NEUROIMMUNOLOGY, 2015, 281 :51-60
[6]  
ALROY I, 1995, MOL CELL BIOL, V15, P5789
[7]  
Aranow C, 2011, J INVEST MED, V59, P881, DOI 10.2310/JIM.0b013e31821b8755
[8]   Vitamin D deficiency in patients with myasthenia gravis and improvement of fatigue after supplementation of vitamin D3: a pilot study [J].
Askmark, H. ;
Haggard, L. ;
Nygren, I. ;
Punga, A. R. .
EUROPEAN JOURNAL OF NEUROLOGY, 2012, 19 (12) :1554-1560
[9]   TH-17 cells in the circle of immunity and autoimmunity [J].
Bettelli, Estelle ;
Oukka, Mohamed ;
Kuchroo, Vijay K. .
NATURE IMMUNOLOGY, 2007, 8 (04) :345-350
[10]   1α,25-dihydroxyvitamin D3 has a direct effect on naive CD4+ T cells to enhance the development of Th2 cells [J].
Boonstra, A ;
Barrat, FJ ;
Crain, C ;
Heath, VL ;
Savelkoul, HFJ ;
O'Garra, A .
JOURNAL OF IMMUNOLOGY, 2001, 167 (09) :4974-4980